Current Mass Spectrometry, Biotech, and Pharma News

• FDA Accepts Biogen Idec’s Biologics License Application for First Long-Lasting Factor VIII Therapy for Hemophilia A (5/13)

• Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers (5/13)

• Agilent Technologies Introduces AdvanceBio Peptide Mapping Columns (5/13)

• Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis (5/10)

• GSK: BREO™ ELLIPTA™ gains US approval for the treatment of COPD (5/10)

• Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma (5/10)

• GSK and Save the Children form unique partnership to save the lives of one million children (5/9)

• GSK enters new commitment with the GAVI Alliance to supply cervical cancer vaccine for girls in the world’s poorest countries (5/9)

• GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Merck’s HPV Vaccine, Available to Developing Countries through UNICEF Tender (5/9)